Skip to main content
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
23.00
+0.10 (0.44%)
Last updated: Aug 14, 2025

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 256.46M EUR in the quarter ending June 30, 2025, with 1.13% growth. This brings the company's revenue in the last twelve months to 975.68M, up 2.86% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.

Revenue (ttm)
975.68M
Revenue Growth
+2.86%
P/S Ratio
3.54
Revenue / Employee
204.33K
Employees
4,690
Market Cap
3.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.38B
Merck KGaA 21.22B
Bayer Aktiengesellschaft 46.17B
Fresenius SE & Co. KGaA 22.28B
Fresenius Medical Care AG 19.52B
Sartorius Aktiengesellschaft 3.47B
Fielmann Group AG 2.33B
Carl Zeiss Meditec AG 2.18B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News